These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8383181

  • 1. Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus.
    Massaer M, Haumont M, Place M, Bollen A, Jacobs P.
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():491-4. PubMed ID: 8383181
    [Abstract] [Full Text] [Related]

  • 2. Purification and characterization of recombinant varicella-zoster virus glycoprotein gpII, secreted by Chinese hamster ovary cells.
    Jacquet A, Massaer M, Haumont M, Houard S, Deleersnyder V, Place M, Bollen A, Jacobs P.
    Protein Expr Purif; 1995 Feb; 6(1):91-8. PubMed ID: 7756843
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant.
    Ludvíková V, Kunke D, Hamsíková E, Kutinová L, Vonka V.
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1445-9. PubMed ID: 1646285
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.
    Cranage MP, Kouzarides T, Bankier AT, Satchwell S, Weston K, Tomlinson P, Barrell B, Hart H, Bell SE, Minson AC.
    EMBO J; 1986 Nov; 5(11):3057-63. PubMed ID: 3024973
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine.
    Vafai A.
    Vaccine; 1993 Nov; 11(9):937-40. PubMed ID: 8212841
    [Abstract] [Full Text] [Related]

  • 9. Immunization with Varicella-zoster virus glycoprotein E expressing vectors: Comparison of antibody response to DNA vaccine and recombinant vaccinia virus.
    Stasíková J, Kutinová L, Smahel M, Nĕmecková S.
    Acta Virol; 2003 Nov; 47(1):1-10. PubMed ID: 12828337
    [Abstract] [Full Text] [Related]

  • 10. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus.
    Kutinová L, Hainz P, Ludvíková V, Maresová L, Nĕmecková S.
    Virology; 2001 Feb 15; 280(2):211-20. PubMed ID: 11162835
    [Abstract] [Full Text] [Related]

  • 11. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
    Garcia-Valcarcel M, Fowler WJ, Harper DR, Jeffries DJ, Layton GT.
    Vaccine; 1997 Feb 15; 15(6-7):709-19. PubMed ID: 9178473
    [Abstract] [Full Text] [Related]

  • 12. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).
    Kinchington PR, Ling P, Pensiero M, Moss B, Ruyechan WT, Hay J.
    J Virol; 1990 Sep 15; 64(9):4540-8. PubMed ID: 2166829
    [Abstract] [Full Text] [Related]

  • 13. A human monoclonal antibody against varicella-zoster virus glycoprotein III.
    Sugano T, Tomiyama T, Matsumoto Y, Sasaki S, Kimura T, Forghani B, Masuho Y.
    J Gen Virol; 1991 Sep 15; 72 ( Pt 9)():2065-73. PubMed ID: 1654371
    [Abstract] [Full Text] [Related]

  • 14. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
    Lowry PW, Solem S, Watson BN, Koropchak CM, Thackray HM, Kinchington PR, Ruyechan WT, Ling P, Hay J, Arvin AM.
    J Gen Virol; 1992 Apr 15; 73 ( Pt 4)():811-9. PubMed ID: 1321876
    [Abstract] [Full Text] [Related]

  • 15. Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody.
    Sullivan V, Smith GL.
    J Gen Virol; 1987 Oct 15; 68 ( Pt 10)():2587-98. PubMed ID: 2822841
    [Abstract] [Full Text] [Related]

  • 16. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies.
    Keller PM, Lonergan K, Neff BJ, Morton DA, Ellis RW.
    J Virol Methods; 1986 Sep 15; 14(2):177-88. PubMed ID: 3021804
    [Abstract] [Full Text] [Related]

  • 17. Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system.
    Yao Z, Jackson W, Forghani B, Grose C.
    J Virol; 1993 Jan 15; 67(1):305-14. PubMed ID: 8380078
    [Abstract] [Full Text] [Related]

  • 18. Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology.
    Thomsson E, Persson L, Grahn A, Snäll J, Ekblad M, Brunhage E, Svensson F, Jern C, Hansson GC, Bäckström M, Bergström T.
    J Virol Methods; 2011 Jul 15; 175(1):53-9. PubMed ID: 21540058
    [Abstract] [Full Text] [Related]

  • 19. Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene.
    Aldaz-Carroll L, Whitbeck JC, Ponce de Leon M, Lou H, Pannell LK, Lebowitz J, Fogg C, White CL, Moss B, Cohen GH, Eisenberg RJ.
    Virology; 2005 Oct 10; 341(1):59-71. PubMed ID: 16083934
    [Abstract] [Full Text] [Related]

  • 20. Transcription mapping of glycoprotein I (gpI) and gpIV of varicella-zoster virus and immunological analysis of the gpI produced in cells infected with the recombinant vaccinia virus.
    Kato T, Kitamura K, Hayakawa Y, Takahashi M, Kojima A, Sato S, Yamanishi K.
    Microbiol Immunol; 1989 Oct 10; 33(4):299-312. PubMed ID: 2549343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.